CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Lymphatica Medtech S.A. has developed LymphoDrain, an implantable system designed to replace the lymphatic vessel function to treat chronic lymphedema. Utilizing a magnetically controlled micro-pump, it aims to provide effective treatment for over 15 million people suffering from this condition in Europe and the US.
Lymphatica Medtech S.A. is a spin-off company created in 2017, from the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Lausanne University Hospital (CHUV).
It has designed and patented “LymphoDrain” a novel implantable system to replace the lymphatic vessel draining function to treat lymphatic disorders, in particular chronic lymphedema.
It uses an underlying technology based on a magnetically controlled micro-pump coupled with draining catheters.
LymphoDrain was develope…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
